BACKGROUND: We sought to systematically evaluate whether percutaneous
revascularization is associated with additional clinical benefit in patients with renal artery …

Aims: Patients with renal artery stenosis are treated with percutaneous intervention, but
randomised studies are inconclusive. We aimed to compare renal percutaneous …

Background Percutaneous revascularization (PR) of atherosclerotic renal artery stenosis
(RAS) improves patency in the renovascular disease. However, whether PR is associated …

The aim of the study was to compare the efficacy of revascularization versus medical therapy
in patients with atherosclerotic renal artery stenosis (ARAS). ARAS is the most common …

Renal artery stenosis (RAS) is usually caused by atherosclerosis or fibromuscular dysplasia.
RAS leads to activation of the renin-angiotensin-aldosterone system and may result in …

Endovascular procedures may play a role in renal artery stenosis (RAS) treatment in attempt
to preserve renal function and improve hypertension control. We determined renal outcome …

Atherosclerotic renal artery stenosis is the leading cause of secondary hypertension and
may lead to resistant (refractory) hypertension, progressive decline in renal function, and …

Atherosclerotic renal artery stenosis is known to be one of the most common causes of
secondary hypertension, and early nonrandomized studies suggested that renal artery …

Background Percutaneous revascularization of the renal arteries improves patency in
atherosclerotic renovascular disease, yet evidence of a clinical benefit is limited. Methods In …

Background: Atherosclerotic renal artery stenosis is increasingly common in an aging
population. Therapeutic options include medical treatment only or revascularization …